Trade SLGL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Sol-Gel Technologies Ltd. (SLGL) is trading at US$63.57, down 3.69% today as of Nov 5, 13:14 EST. The company has a market capitalisation of US$254.1M. Over the past 52 weeks, SLGL has traded between US$28.81 and US$97.97. On Syfe you can trade SLGL with $0 commission and add it to your watchlist.
| Previous close | US$66.00 |
|---|---|
| Market cap | US$254.1M |
| 52-week range | US$28.81 – US$97.97 |
| Volume | 32.83K |
| Exchange | US |
Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
Year: 2018
Mizuho Securities Initiates Coverage on Sol-Gel With Outperform Rating, $285 Price Target
Jun 24, 11:37 AM · MT Newswires
--TD Cowen Initiates Sol-Gel Technologies at Buy
May 29, 9:55 AM · MT Newswires
Sol-Gel Technologies Ltd. (SLGL) stock is trading at US$63.57, -3.69% from the previous close of US$66.00.
The market cap for Sol-Gel Technologies Ltd. (SLGL) stock is approximately US$254.1M.
The 52-week high for Sol-Gel Technologies Ltd. (SLGL) stock is US$97.97.
The 52-week low for Sol-Gel Technologies Ltd. (SLGL) stock is US$28.81.
Sol-Gel Technologies Ltd. (SLGL) does not currently pay a dividend.
Stay on top of SLGL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
